Koninklijke Philips | PHG - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Abbott USD 2.25B 73M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Danaher USD 1.5B 348M 2025-12
Demant DKK 2.09B 224M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Fresenius EUR 713M 139M 2025-12
General Electric Aerospace USD 1.77B 536M 2025-12
Getinge SEK 1.08B 900M 2024-12
Globus Medical USD 181.31M 298.83M 2025-12
GN Store Nord DKK 570M 230M 2025-12
Hitachi JPY 317.67B 20.64B 2025-12
Idexx Laboratories USD 315.6M 39.24M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
J&J USD 6.62B 1.03B 2026-03
Koninklijke Philips EUR 836.93M 308.63M 2025-12
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Philips EUR 719M 390M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Smith & Nephew USD 440M 50M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12